Double Lung Transplantation for Idiopathic Pulmonary Fibrosis in a Patient with a History of Liver Transplantation and Prolonged Journey for Disease-Specific Antifibrotic Therapy

Idiopathic pulmonary fibrosis (IPF) is characterized by uncontrolled progressive lung fibrosis with a median survival of 3 to 5 years. Although currently available pharmacotherapy cannot cure the disease, antifibrotics including pirfenidone and nintedanib were shown to slow disease progression and i...

Descripción completa

Detalles Bibliográficos
Autores principales: Majewski, Sebastian, Królikowska, Maria, Costabel, Ulrich, Piotrowski, Wojciech J., Ochman, Marek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9392625/
https://www.ncbi.nlm.nih.gov/pubmed/35996614
http://dx.doi.org/10.1155/2022/4054339

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9392625/
https://www.ncbi.nlm.nih.gov/pubmed/35996614
http://dx.doi.org/10.1155/2022/4054339

Ejemplares similares